Diclofenac and tobramycin formulations for ophthalmic and otic t

Drug – bio-affecting and body treating compositions – Topical body preparation containing solid synthetic organic... – Ophthalmic preparation

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 7805, 514912, 514914, A61K 3174

Patent

active

055975607

ABSTRACT:
This invention includes a pharmaceutically acceptable formulation of Diclofenac, Tobramycin, a solubility agent and, optionally, excipients, tonicifiers, buffers, viscosity modifying agents, preservatives, and chelating agents, at a pH from greater than 7.0 to about 9. The invention also discloses the use of this pharmaceutically acceptable formulation of an antibiotic and NSAIDs to treat eye and ear conditions accompanied by infection and inflammation.

REFERENCES:
patent: 4087538 (1978-05-01), Portnoff
patent: 4407792 (1983-10-01), Schoenwald et al.
patent: 4478822 (1984-10-01), Hasam et al.
patent: 4668506 (1987-05-01), Bawa
patent: 4829088 (1989-05-01), Doulakas
Human Conjunctivitis, Howard M. Leibowitz, MD, et al., Arch Ophthalmol, vol. 94, Oct. 1976, pp. 1752-1756.
Association diclofenac-dexamethasone dans le traitement de l'inflammation postoperatoire: etude prospective en double-insu, Dr. Philippe Othenin-Girard, et al., Klin. Mbl. Augenheilk, 200, 1992, pp. 362-366.
The Effect of 0.1% Indomethacin Eyedrops on Cataract Surgery, Journal of Ocular Pharmacology, vol. 7, No. 1, 1991, pp. 77-81.
The Effect of Ketorolac Tromethamine in Reducing Postoperative Inflamation: Double-Mask Parallel Comparison with Dexamethasone, Allan J. Flach, MD, et al., Ann Ophthalmol 1989; 21:407-411.
Infections of the Eye--35. Endophthalmitis, David W. Parke II, et al., pp. 563-583.
Incompatibility of indometacin and benzalkonium in eye drops due to ion-pair formation, S. M. Dreijer-Van Der Glas, et al., vol. 9, 1987, Pharmaceutisch Weekblad Scientific Edition, pp. 29-32.
Effects of Pretreatment with Mydriatics on Intraocular Penetration of 0.1% Pranoprofen, Takahiro Ogawa, et al., Jpn J Ophthalmol, vol. 37: 47-55, 1993.
Prediction of Skin Permeability of Drugs: Comparison of Human and Hairless Rat Skin, Yasunori Morimoto, et al., J. Pharm. Pharmacol. 1992, 44: 634-639.
Binary Diclogenac Diethylamine-Water Systems: Micelles, Vesicles and Lyotropic Liquid Crystals, Katrin Kriwet, et al., Eur. J. Pharm. Biopharm, 39 (6) 234-238, 1993.
Degradation of Tobramycin in Aqueous Solution, Michael Brandl and Leo Gu, Drug Development and Industrial Pharmacy, 18(13), 1423-1436, 1992.
Spectrophotometric Method for Determination of Tobramycin, Apramycin and Kanamycin in Formulations, P. R. Bontchev, et al., Mikrochimica Acta (wien) 1984 III, 459-465.
The Top Ten NSAIDs - A molecular modelling study, S. Winiwarter, et al., Pharmaceutica Acta Helvetiae 68 (1994) 181-189.
Conjunctival Disorders, Current Veterinary Therapy X Small Animal Practice, Cecil P. Moore, D.V.M., 1989, pp. 673-678.
A New Corticosteroid-Antibiotic Preparation in Eye and Ear Infections, General Practitioner Clinical Trials, Alexander, J. et al., Jul., 1966, vol. 197: 94-96.
Canine Conjunctiva and Nictitating Membrane, Veterinary Ophthalmology, Dennis E. Brooke, pp. 290-304, 1991.
Diseases of the Ear, Textbook of Veterinary Internal Medicine -- Diseases of the Dog and Cat, vol. I, Dennis W. Macy, pp. 246-257.
American Academy of Ophthalmology, Final Program, Scientific Posters, p. 101.
XXVIIth International Congress of Ophthalmology '94, Final Program, Scientific Papers.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diclofenac and tobramycin formulations for ophthalmic and otic t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diclofenac and tobramycin formulations for ophthalmic and otic t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diclofenac and tobramycin formulations for ophthalmic and otic t will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-940070

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.